• Exchange: New York
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

ZTS:US

43.5100 USD 0.3600 0.83%

As of 20:04:05 ET on 12/19/2014.

Snapshot for Zoetis Inc (ZTS)

Open: 43.0300 Day's Range: 42.6300 - 43.7300 Volume: 5,601,641
Previous Close: 43.1500 52wk Range: 28.1350 - 45.2400 1-Yr Rtn: +35.55%

Stock Chart for ZTS

No chart data available.
  • ZTS:US 43.5100
  • 1D
  • 1M
  • 1Y
43.1500
Interactive ZTS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ZTS

Current P/E Ratio (ttm) 29.7596
Estimated P/E(12/2014) 28.4565
Relative P/E vs. SPX 1.6242
Earnings Per Share (USD) (ttm) 1.4621
Est. EPS (USD) (12/2014) 1.5290
Est. PEG Ratio 2.3953
Market Cap (M USD) 21,812.64
Shares Outstanding (M) 501.32
30 Day Average Volume 6,184,839
Price/Book (mrq) 15.9876
Price/Sale (ttm) 4.6162
Dividend Indicated Gross Yield 0.76%
Cash Dividend (USD) 0.0830
Dividend Ex-Date 01/20/2015
5 Year Dividend Growth -
Next Earnings Announcement 02/11/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ZTS

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ZTS

Zoetis Inc discovers, develops, manufactures and commercializes animal health medicines and vaccines, with a focus on both livestock and companion animals. The Companies products are sold in North America, Europe, Africa, Asia, Australia and Latin America.

Juan Ramon AlaixChief Executive OfficerCarolyn HawverPres:Global Manufacturing & Supply
Kristin C PeckExec VP/Group PresidentPaul S HerendeenExec VP/CFO
More Company Profile & Key Executives for ZTS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil